Preexisting Anemia Can Intensify Malaria Severity, New Study Shows

A new study shows that preexisting anemia can significantly worsen the severity of malaria, highlighting potential new treatment strategies targeting reticulocytes to combat the disease more effectively.
Recent research conducted by the University of Toledo highlights a concerning link between preexisting anemia and the progression of malaria. Published in the peer-reviewed journal Infection and Immunity, the study reveals that individuals with anemia are at a significantly higher risk of developing severe complications if infected by the malaria parasite.
Malaria, primarily caused by parasite invasion of red blood cells, is a major global health challenge, especially in endemic regions. Symptoms such as fever, chills, fatigue, and headaches can escalate into life-threatening conditions, including organ damage and coma. While it is known that malaria can lead to anemia due to destruction of red blood cells, the new findings suggest that having anemia beforehand can worsen the disease’s impact.
The research team studied mice with two types of anemia—one from blood loss and another from red blood cell breakdown—and infected them with malaria. Results showed that anemic mice had higher parasite loads, more weight loss, and more liver damage compared to healthy mice. The increased presence of reticulocytes—immature red blood cells released during anemia—appears to be a key factor, as these cells are more susceptible to malaria infection.
Intriguingly, the researchers tested interventions to reduce reticulocyte levels. They provided blood transfusions from healthy mice and employed a monoclonal antibody targeting receptors on reticulocytes. Both treatments successfully lowered parasite levels and improved health outcomes, indicating potential new avenues for malaria treatment.
While blood transfusions are already used to treat malaria-associated anemia, their role in directly combating malaria warrants further exploration. The antibody approach, more targeted and effective in the study, could represent a groundbreaking therapeutic strategy, especially as the targeted antibodies are currently being studied for cancer treatments.
This research underscores the importance of addressing anemia in malaria-endemic areas, where nutritional deficiencies and preexisting anemia are prevalent. Targeting reticulocytes may offer a novel approach to reducing the severity of malaria infections, saving lives, and informing future treatment protocols.
Source: https://medicalxpress.com/news/2025-08-preexisting-anemia-malaria-worse.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Increased Risk of Hospital Readmission Within 30 Days for Patients with Substance Use Disorders
Patients with substance use disorders face a 24% higher risk of hospital readmission within 30 days post-discharge. New UCLA research highlights the need for targeted interventions to improve outcomes and reduce healthcare costs.
Genetic Factors Underlying Sudden Cardiac Death Elevate Heart Failure Risks in Dilated Cardiomyopathy Patients
A comprehensive Spanish study reveals that genetic mutations linked to sudden cardiac death significantly increase the risk of severe heart failure in patients with dilated cardiomyopathy, emphasizing the importance of early detection and personalized treatment strategies.
Genetic Variants as Key Factors in Diverse Clinical Outcomes of Complex Disorders
Emerging research reveals that secondary genetic variants significantly influence the clinical diversity seen in complex disorders, emphasizing the importance of genetic background and cohort selection in understanding disease variability.



